While SAMD9 has been characterized as a tumor suppressor in lung, breast, and colon cancer [14, 15], its role in glioma is paradoxical, as it has been reported to drive tumor progression by regulating HOXB8 [16]. Here, SAMD9 is linked to central nervous system cancer.